DICE Therapeutics, Inc.
DICEDelisted Aug 9, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645569
DICE Therapeutics, Inc. was delisted on Aug 9, 2023; its insiders filed their last Form 4 on Aug 9, 2023; 160 institutions reported holding it in 13F filings for Q2 2023, worth $2.12B in total; Fairfax Financial was the only superinvestor holding it.
Q4 2022 vs. Q3 2022
How the institutions holding DICE Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 79 | 109 | +30 |
| Shares | 36.9M | 47.5M | +10.6M (+28.7%) |
| Value | $748.2M | $1.48B | +$732.7M (+97.9%) |
New holders (42)
Institutions that held DICE Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (12)
Institutions that held DICE Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Miller Investment Management, LP | 180,901 | $3.67M |
| Sphera Funds Management Ltd. | 152,913 | $3.10M |
| Nicholas Investment Partners, LP | 97,838 | $1.98M |
| Parallax Volatility Advisers, L.P. | 71,779 | $1.46M |
| Prelude Capital Management, LLC | 15,842 | $321.0K |
| Cutler Group LP | 15,352 | $311.0K |
| Group One Trading, L.P. | 13,871 | $281.0K |
| Ensign Peak Advisors, Inc | 11,177 | $227.0K |
| Chicago Partners Investment Group LLC | 6,588 | $204.0K |
| Acuta Capital Partners, LLC | 6,700 | $136.0K |
| IFP Advisors, Inc | 325 | $12.0K |
| Massmutual Trust Co FSB | 30 | $1.00K |